Mitsubishi UFJ Asset Management
ADMA icon

Mitsubishi UFJ Asset Management’s ADMA Biologics ADMA Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.73K Hold
1,162
– – ﹤0.01% 1460
2026
Q1 		$10.5K Hold
1,162
– – ﹤0.01% 1380
2025
Q4 		$20.8K Hold
1,162
– – ﹤0.01% 1225
2025
Q3 		$17K Hold
1,162
– – ﹤0.01% 1242
2025
Q2 		$21.2K Hold
1,162
– – ﹤0.01% 1181
2025
Q1 		$23.1K Hold
1,162
– – ﹤0.01% 1124
2024
Q4 		$21.4K Hold
1,162
– – ﹤0.01% 1149
2024
Q3 		$23.2K Buy
+1,162
New +$18.1K ﹤0.01% 1110

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Mitsubishi UFJ Asset Management's ADMA Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management held its ADMA Biologics (ADMA) position steady in Q2 2026 at 1,162 shares worth $9.73K. The position accounts for ﹤0.01% of the portfolio, ranked #1460.

Mitsubishi UFJ Asset Management first reported a position in ADMA in Q3 2024 and has held it in 8 quarters since. The position peaked at $23.2K in Q3 2024. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 1,162 shares of ADMA Biologics worth $9.73K as of Q2 2026.
  • Mitsubishi UFJ Asset Management left its ADMA Biologics share count unchanged in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1460 holding.
  • Mitsubishi UFJ Asset Management first reported a position in ADMA Biologics in Q3 2024 and has held it in 8 quarters since.
  • Mitsubishi UFJ Asset Management's ADMA Biologics position peaked at $23.2K in Q3 2024.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.